Imugene Ltd (IMU) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.620x

Based on the latest financial reports, Imugene Ltd (IMU) has a cash flow conversion efficiency ratio of -0.620x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$-25.97 Million ≈ $-18.38 Million USD) by net assets (AU$41.87 Million ≈ $29.62 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Imugene Ltd (IMU) liquidity interval to measure how many days the company can operate on defensive assets alone.

Imugene Ltd - Cash Flow Conversion Efficiency Trend (1993–2025)

This chart illustrates how Imugene Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Imugene Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Imugene Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Hudson Global Inc
NASDAQ:HSON
0.003x
Kunming Longjin Pharmaceutical Co Ltd
SHE:002750
-0.014x
Gunpoint Exploration Ltd
V:GUN
-0.013x
Drone Volt SA
PA:ALDRV
-0.254x
Shengfeng Development Limited Class A Ordinary Shares
NASDAQ:SFWL
-0.112x
PTL LTD Ordinary Shares
NASDAQ:PTLE
-0.445x
FiEE, Inc.
NASDAQ:FIEE
0.007x
Nexam Chemical Holding AB
ST:NEXAM
-0.024x

Annual Cash Flow Conversion Efficiency for Imugene Ltd (1993–2025)

The table below shows the annual cash flow conversion efficiency of Imugene Ltd from 1993 to 2025. For the full company profile with market capitalisation and key ratios, see Imugene Ltd (IMU) total market value.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$45.03 Million
≈ $31.86 Million
AU$-75.57 Million
≈ $-53.47 Million
-1.678x -95.07%
2024-06-30 AU$118.25 Million
≈ $83.67 Million
AU$-101.73 Million
≈ $-71.98 Million
-0.860x -447.78%
2023-06-30 AU$189.63 Million
≈ $134.17 Million
AU$-29.78 Million
≈ $-21.07 Million
-0.157x +28.98%
2022-06-30 AU$138.70 Million
≈ $98.14 Million
AU$-30.67 Million
≈ $-21.70 Million
-0.221x -9.50%
2021-06-30 AU$65.02 Million
≈ $46.00 Million
AU$-13.13 Million
≈ $-9.29 Million
-0.202x -19.19%
2020-06-30 AU$59.81 Million
≈ $42.32 Million
AU$-10.13 Million
≈ $-7.17 Million
-0.169x +41.54%
2019-06-30 AU$27.29 Million
≈ $19.31 Million
AU$-7.91 Million
≈ $-5.60 Million
-0.290x +0.52%
2018-06-30 AU$15.48 Million
≈ $10.95 Million
AU$-4.51 Million
≈ $-3.19 Million
-0.291x -24.18%
2017-06-30 AU$11.39 Million
≈ $8.06 Million
AU$-2.67 Million
≈ $-1.89 Million
-0.235x +39.56%
2016-06-30 AU$7.86 Million
≈ $5.56 Million
AU$-3.05 Million
≈ $-2.16 Million
-0.388x -46.86%
2015-06-30 AU$7.73 Million
≈ $5.47 Million
AU$-2.04 Million
≈ $-1.45 Million
-0.264x -55.52%
2014-06-30 AU$6.73 Million
≈ $4.76 Million
AU$-1.14 Million
≈ $-809.52K
-0.170x +76.58%
2013-06-30 AU$1.89 Million
≈ $1.33 Million
AU$-1.37 Million
≈ $-968.40K
-0.726x +19.38%
2012-06-30 AU$1.07 Million
≈ $759.51K
AU$-965.92K
≈ $-683.45K
-0.900x -447.17%
2011-06-30 AU$4.21 Million
≈ $2.98 Million
AU$1.09 Million
≈ $771.53K
0.259x +156.39%
2010-06-30 AU$3.79 Million
≈ $2.68 Million
AU$-1.74 Million
≈ $-1.23 Million
-0.460x -377.67%
2009-06-30 AU$5.33 Million
≈ $3.77 Million
AU$881.77K
≈ $623.91K
0.166x +160.74%
2008-06-30 AU$4.67 Million
≈ $3.30 Million
AU$-1.27 Million
≈ $-900.66K
-0.273x +24.77%
2007-06-30 AU$4.70 Million
≈ $3.33 Million
AU$-1.70 Million
≈ $-1.20 Million
-0.362x -27.73%
2006-06-30 AU$6.46 Million
≈ $4.57 Million
AU$-1.83 Million
≈ $-1.30 Million
-0.284x -50.67%
2005-06-30 AU$8.65 Million
≈ $6.12 Million
AU$-1.63 Million
≈ $-1.15 Million
-0.188x +32.68%
2004-06-30 AU$5.43 Million
≈ $3.84 Million
AU$-1.52 Million
≈ $-1.07 Million
-0.280x +71.84%
2002-06-30 AU$792.83K
≈ $560.98K
AU$-787.36K
≈ $-557.11K
-0.993x -108.81%
2001-06-30 AU$-226.54K
≈ $-160.29K
AU$-2.55 Million
≈ $-1.81 Million
11.266x +892.20%
2000-06-30 AU$2.78 Million
≈ $1.97 Million
AU$-3.95 Million
≈ $-2.80 Million
-1.422x -147.09%
1999-06-30 AU$6.00 Million
≈ $4.24 Million
AU$-3.45 Million
≈ $-2.44 Million
-0.576x -99.40%
1997-06-30 AU$7.45 Million
≈ $5.27 Million
AU$-2.15 Million
≈ $-1.52 Million
-0.289x -16.06%
1996-06-30 AU$8.12 Million
≈ $5.75 Million
AU$-2.02 Million
≈ $-1.43 Million
-0.249x -58.27%
1995-06-30 AU$10.62 Million
≈ $7.52 Million
AU$-1.67 Million
≈ $-1.18 Million
-0.157x -20.81%
1994-06-30 AU$11.19 Million
≈ $7.91 Million
AU$-1.46 Million
≈ $-1.03 Million
-0.130x -235.76%
1993-06-30 AU$5.11 Million
≈ $3.62 Million
AU$-198.00K
≈ $-140.10K
-0.039x --

About Imugene Ltd

AU:IMU Australia Biotechnology
Market Cap
$34.56 Million
AU$48.84 Million AUD
Market Cap Rank
#23297 Global
#881 in Australia
Share Price
AU$0.12
Change (1 day)
+21.05%
52-Week Range
AU$0.01 - AU$0.48
All Time High
AU$0.61
About

Imugene Limited, a clinical-stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumours in Australia. Its lead products under development azer-cel, an allogeneic CAR T cell therapy in phase 1 clinical trial targeting relapsed/refractory non-hodgkin lymphoma and b-cell acute lymphoblastic leukemia; CF33 VAXINIA,… Read more